Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Parnis, Francis"" wg kryterium: Autor


Tytuł:
Treatment patterns and outcomes in older adults with castration-resistant prostate cancer: Analysis of an Australian real-world cohort
Autorzy:
Fernando, Michael
Anton, Angelyn
Weickhardt, Andrew
Azad, Arun A.
Uccellini, Anthony
Brown, Stephen
Wong, Shirley
Parente, Phillip
Shapiro, Julia
Liow, Elizabeth
Torres, Javier
Goh, Jeffrey
Parnis, Francis
Steer, Christopher
Warren, Mark
Gibbs, Peter
Tran, Ben
Pokaż więcej
Źródło:
In Journal of Geriatric Oncology November 2023 14(8)
Czasopismo naukowe
Tytuł:
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
Autorzy:
Saad, Fred
Oya, Mototsugu
Shore, Neal
Procopio, Giuseppe
Guedes, João Daniel
Arslan, Cagatay
Mehra, Niven
Parnis, Francis
Brown, Emma
Schlürmann, Friederike
Joung, Jae Young
Sugimoto, Mikio
Sartor, Oliver
Liu, Yu-Zhen
Poehlein, Christian
Barker, Laura
del Rosario, Paula Michelle
Armstrong, Andrew J
Pokaż więcej
Źródło:
In The Lancet Oncology October 2023 24(10):1094-1108
Czasopismo naukowe
Tytuł:
Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma
Autorzy:
Ernst, Matthew S.
Navani, Vishal
Wells, J. Connor
Donskov, Frede
Basappa, Naveen
Labaki, Chris
Pal, Sumanta K.
Meza, Luis
Wood, Lori A.
Ernst, D. Scott
Szabados, Bernadett
McKay, Rana R.
Parnis, Francis
Suarez, Cristina
Yuasa, Takeshi
Lalani, Aly-Khan
Alva, Ajjai
Bjarnason, Georg A.
Choueiri, Toni K.
Heng, Daniel Y.C.
Pokaż więcej
Źródło:
In European Urology July 2023 84(1):109-116
Czasopismo naukowe
Tytuł:
Testosterone suppression plus enzalutamide versus testosterone suppression plus standard antiandrogen therapy for metastatic hormone-sensitive prostate cancer (ENZAMET): an international, open-label, randomised, phase 3 trial
Autorzy:
Abdi, Ehtesham
Allan, Suzanne
Bastick, Patricia
Begbie, Stephen
Blum, Robert
Briscoe, Karen
Brungs, Daniel
Bydder, Sean
Chittajallu, Bala Renuka
Cronk, Michelle
Cuff, Katharine
Davis, Ian D
Dowling, Anthony
Frydenberg, Mark
George, Matthew
Horvath, Lisa
Hovey, Elizabeth
Joshua, Anthony
Karanth, Narayan
Kichenadasse, Ganessan
Krieger, Laurence
Marx, Gavin
Mathlum, Maitham
Nott, Louise
Otty, Zulfiquer
Parnis, Francis
Pook, David
Sandhu, Shahneen
Sewak, Sanjeev
Stevanovic, Amanda
Stockler, Martin
Suder, Aneta
Tan, Hsiang
Torres, Javier
Troon, Simon
Underhill, Craig
Weickhardt, Andrew
Zielinski, Robert
Abbas, Tahir
Anan, Ghadeer
Booth, Chris
Campbell, Holly
Chi, Kim
Chin, Joseph
Chouinard, Edmond
Donnelly, Bryan
Drachenberg, Darrel
Faghih, Amir
Finelli, Antonio
Hotte, Sebastien
Noonan, Krista
North, Scott
Rassouli, Mohammad
Reaume, Neil
Rendon, Ricardo
Saad, Fred
Sadikov, Evgeny
Vigneault, Eric
Zalewski, Pawel
McCaffrey, John
McDermott, Ray
Morris, Patrick
O'Connor, Miriam
Donnellan, Paul
O'Donnell, Dearbhaile
Edwards, Jim
Fong, Peter
Tan, Alvin
Chowdhury, Simon
Crabb, Simon
Khan, Omar
Khoo, Vincent
Macdonald, Graham
Payne, Heather
Robinson, Angus
Shamash, Jonathon
Staffurth, John
Thomas, Carys
Thomson, Alastair
Sweeney, Christopher J
Martin, Andrew J
Stockler, Martin R
Cheung, Leanna
Chi, Kim N
Horvath, Lisa G
Joshua, Anthony M
Lawrence, Nicola J
McJannett, Margaret
North, Scott A
Parulekar, Wendy
Pook, David W
Reaume, Martin Neil
Sandhu, Shahneen K
Tan, Thean Hsiang
Vera-Badillo, Francisco
Williams, Scott G
Winter, Diana
Yip, Sonia
Zhang, Alison Y
Zielinski, Robert R
Pokaż więcej
Źródło:
In The Lancet Oncology April 2023 24(4):323-334
Czasopismo naukowe
Tytuł:
Patient-reported Outcomes from JAVELIN Bladder 100: Avelumab First-line Maintenance Plus Best Supportive Care Versus Best Supportive Care Alone for Advanced Urothelial Carcinoma
Autorzy:
Grivas, Petros
Kopyltsov, Evgeny
Su, Po-Jung
Parnis, Francis X.
Park, Se Hoon
Yamamoto, Yoshiaki
Fong, Peter C.
Tournigand, Christophe
Climent Duran, Miguel A.
Bamias, Aristotelis
Caserta, Claudia
Chang, Jane
Cislo, Paul
di Pietro, Alessandra
Wang, Jing
Powles, Thomas
Pokaż więcej
Źródło:
In European Urology April 2023 83(4):320-328
Czasopismo naukowe
Tytuł:
Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
Autorzy:
Bakouny, Ziad
El Zarif, Talal
Dudani, Shaan
Connor Wells, J.
Gan, Chun Loo
Donskov, Frede
Shapiro, Julia
Davis, Ian D.
Parnis, Francis
Ravi, Praful
Steinharter, John A.
Agarwal, Neeraj
Alva, Ajjai
Wood, Lori
Kapoor, Anil
Ruiz Morales, Jose M.
Kollmannsberger, Christian
Beuselinck, Benoit
Xie, Wanling
Heng, Daniel Y.C.
Choueiri, Toni K.
Pokaż więcej
Źródło:
In European Urology February 2023 83(2):145-151
Czasopismo naukowe
Tytuł:
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Autorzy:
Tomczak, Piotr
Choueiri, Toni
Park, Se Hoon
Venugopal, Balaji
Ferguson, Thomas R.
Hajek, Jaroslav
Lin, Tzu-Ping
Symeonides, Stefan N.
Lee, Jae Lyun
Sawrycki, Piotr
Haas, Naomi B.
Gurney, Howard P.
Mahave, Mauricio
Sarwar, Naveed
Thiery-Vuillemin, Antoine
Gross-Goupil, Marine
Chevreau, Christine
Burke, John M.
Doshi, Gurjyot
Melichar, Bohuslav
Topart, Delphine
Oudard, Stephane
Kopyltsov, Evgeniy
Hammers, Hans-Joerg
Quinn, David I.
Alva, Ajjai
Menezes, Juliana de Janoski
Silva, Adriano Goncalves e
Winquist, Eric W.
Hamzaj, Alketa
Procopio, Giuseppe
Karaszewska, Boguslawa
Nowakowska-Zajdel, Ewa M.
Alekseev, Boris Y.
Gafanov, Rustem A.
Izmailov, Adel
Semenov, Andrey
Afanasyev, Sergey G.
Lipatov, Oleg N.
Powles, Thomas B.
Srinivas, Sandy
McDermott, David
Kochuparambil, Samith T.
Davis, Ian D.
Peltola, Katriina
Sabbatini, Roberto
Chung, Jinsoo
Shkolnik, Michail I.
Matveev, Vsevolod B.
Gajate Borau, Pablo
McCune, Steven
Hutson, Thomas E.
Dri, Alejandro
Sales, Silvio Correia
Yeung, Carrie
Alcala Castro, Carmen Marcela
Bostrom, Peter
Laguerre, Brigitte
Buttigliero, Consuelo
de Giorgi, Ugo
Fomin, Eugeniy A.
Zakharia, Yousef
Hwang, Clara
Singer, Eric A.
Yorio, Jeffrey T.
Waterhouse, David
Kowalyszyn, Ruben Dario
Alfie, Margarita Sonia
Yanez Ruiz, Eduardo
Buchler, Tomas
Kankaanranta, Krista
Ferretti, Gianluigi
Kimura, Go
Nishimura, Kazuo
Masumori, Naoya
Tamada, Satoshi
Kato, Haruaki
Kitamura, Hiroshi
Danielewicz, Iwona
Wojcik-Tomaszewska, Joanna
Sala Gonzalez, Nuria
Chiu, Kun-Yuan
Atkins, Michael B.
Heath, Elisabeth
Rojas-Uribe, Gustavo Adolfo
Gonzalez Fernandez, Manuel Enrique
Feyerabend, Susan
Pignata, Sandro
Numakura, Kazuyuki
Cybulska Stopa, Bozena
Zukov, Ruslan
Climent Duran, Miguel Angel
Maroto Rey, Pablo Jose
Montesa Pino, Alvaro
Chang, Chao-Hsiang
Vengalil, Salil
Waddell, Tom S.
Cobb, Patrick W.
Hauke, Ralph
Anderson, Daniel M.
Sarantopoulos, John
Gourdin, Theodore
Zhang, Tian
Jayram, Gautam
Fein, Luis Enrique
Harris, Carole
Beato, Patricia Medeiros Milhomem
Flores, Francisco
Estay, Angela
Rubiano, Juan Andres
Bedke, Jens
Hauser, Stefan
Neisius, Andreas
Busch, Jonas
Anai, Satoshi
Tsunemori, Hiroyuki
Sawka, Dariusz
Sikora-Kupis, Bozena
Arranz, Jose Angel
Delgado, Ignacio
Chen, Chung-Hsin
Gunderson, Elizabeth
Tykodi, Scott
Koletsky, Alan
Chen, Kevin
Agrawal, Manish
Kaen, Diego Lucas
Sade, Juan Pablo
Tatangelo, Marcelo Daniel
Parnis, Francis
Barbosa, Fernando Maciel
Faucher, Genevieve
Iqbal, Nayyer
Marceau, Daniele
Paradis, Jean-Benoit
Hanna, Nawar
Acevedo, Alejandro
Ibanez, Carolina
Villanueva, Luis
Galaz, Pedro Pablo
Durango, Isabel Cristina
Manneh, Ray
Kral, Zdenek
Holeckova, Petra
Hakkarainen, Heikki
Ronkainen, Hanna
Abadie-Lacourtoisie, Sophie
Tartas, Sophie
Goebell, Peter J.
Grimm, Marc-Oliver
Hoefner, Thomas
Wirth, Manfred
Panic, Andrej
Schultze-Seemann, Wolfgang
Yokomizo, Akira
Mizuno, Ryuichi
Uemura, Hirotsugu
Eto, Masatoshi
Tsujihata, Masao
Matsukawa, Yoshihisa
Murakami, Yoji
Kim, Miso
Hamberg, Paul
Marczewska-Skrodzka, Malgorzata
Szczylik, Cezary
Humphreys, Alison C.
Jiang, Peter
Kumar, Birendra
Lu, Gary
Desai, Arpita
Karam, Jose Antonio
Keogh, George
Fleming, Mark
Zarba, Juan Jose
Leiva, Viviana E.
Mendez, Guillermo Ariel
Harris, Samuel J.
Brown, Stephen J.
Antonio Junior, Joao Neif
Costamilan, Rita de Cassia
Rocha, Roberto Odebrecht
Muniz, David
Brust, Leandro
Lalani, Aly-Khan
Graham, Jeffrey
Levesque, Michael
Orlandi, Francisco
Kotasek, Rostislav
Deville, Jean L.
Borchiellini, Delphine
Merseburger, Axel
Rink, Michael
Roos, Frederik
McDermott, Ray
Oyama, Masafumi
Yamamoto, Yoshiaki
Tomita, Yoshihiko
Miura, Yuji
Ioritani, Naomasa
Westgeest, Hans
Kubiatowski, Tomasz
Bal, Wieslaw
Girones Sarrio, Regina
Rowe, Julie
Prow, Debra M.
Senecal, Francis
Hashemi-Sadraei, Neda
Cole, Scott W.
Kendall, Stephan D.
Richards, Donald A.
Schnadig, Ian D.
Gupta, Mukul
Powles, Thomas
Ferguson, Thomas
Symeonides, Stefan N
Gurney, Howard
Chang, Yen-Hwa
Haas, Naomi B
Burgents, Joseph E
Xu, Lei
Imai, Kentaro
Quinn, David I
Choueiri, Toni K
Pokaż więcej
Źródło:
In The Lancet Oncology September 2022 23(9):1133-1144
Czasopismo naukowe
Tytuł:
Assessing the Safety and Efficacy of Two Starting Doses of Lenvatinib Plus Everolimus in Patients with Renal Cell Carcinoma: A Randomized Phase 2 Trial
Autorzy:
Pal, Sumanta K.
Puente, Javier
Heng, Daniel Y.C.
Glen, Hilary
Koralewski, Piotr
Stroyakovskiy, Daniil
Alekseev, Boris
Parnis, Francis
Castellano, Daniel
Ciuleanu, Tudor
Lee, Jae Lyun
Sunela, Kaisa
O'Hara, Karen
Binder, Terri A.
Peng, Lixian
Smith, Alan D.
Rha, Sun Young
Pokaż więcej
Źródło:
In European Urology September 2022 82(3):283-292
Czasopismo naukowe
Tytuł:
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
Autorzy:
Parnis, Francis
Joshua, Anthony M.
Horvath, Lisa G.
Steer, Christopher
Marx, Gavin
Sandhu, Shahneen
Gurney, Howard
Ferguson, Thomas
Van Bruwaene, Siska
Luyten, Daisy
Schatteman, Peter
Lumen, Nicolaas
Dirix, Luc
Goeminne, Jean-Charles
Gil, Thierry
Seront, Emmanuel
Vulsteke, Christof
Kussumoto, Celio
Franke, Fabio A.
Martinelli de Oliveira, Fabricio Augusto
Pereira de Santana Gomes, Andrea Juliana
Pinczowski, Hélio
Preto, Daniel D'Almeida
Zucca, Luis Eduardo
Borges, Giuliano Santos
Murad, Andre M.
Saad, Fred
Chi, Kim N.
Fradet, Yves
Fleshner, Neil E.
Emmenegger, Urban
Brasso, Klaus
Fizazi, Karim
Culine, Stephane
Thiery-Vuillemin, Antoine
Joly, Florence
Fléchon, Aude
Hilgers, Werner
Eymard, Jean-Christophe
Borchiellini, Delphine
Barthélémy, Philippe
Berger, Raanan
Leibowitz-Amit, Raya
Mermershtain, Wilmosh
Rouvinov, Keren
Peer, Avivit
Kovel, Svetlana
Sella, Avishay
Lolkema, Martijn P.
van den Eertwegh, Alfonsus J.M.
Voortman, Johannes
Aarts, Maureen J.
Gietema, Jourik A.
Kim, Choung-Soo
Choi, Young-Deuk
Chung, Byung-Ha
Gafanov, Rustem A.
Kopyltsov, Evgeniy
Usynin, Evgeny A.
Carles, Joan
Mellado, Begoña
Maroto, José Pablo
García-Donás, Jesús
Rodríguez Moreno, Juan Francisco
Durán, Ignacio
Pérez-Valderrama, Begoña
Castro, Elena
Olmos, David
Méndez-Vidal, María José
Estellés, David Lorente
Sarrió, Regina Gironés
Muñoz-Langa, José
Herranz, Urbano Anido
Puente Vázquez, Javier
Castellanos, Enrique
Hellström, Martin
Widmark, Anders
Lissbrant, Ingela Franck
Jellvert, Åsa
Külich, Cecilia
Blom, René
Ståhl, Olof
Chiang, Po-Hui
Kang, Chih-Hsiung
Ou, Yen-Chuan
Wang, Shian-Shiang
Wu, Hsi-Chin
Lu, Yu-Chuan
Attard, Gerhardt
Khoo, Vincent
Bahl, Amit
Kellati, Prasad
Parikh, Omi
Srinivasan, Rajaguru
Lester, Jason F.
Staffurth, John N.
Cheng, Heather H.
Efstathiou, Eleni
Pilié, Patrick G.
George, Daniel J.
Karsh, Lawrence I.
Kelly, W. Kevin
Danila, Daniel C.
Sieber, Paul R.
Smith, Matthew R.
Heath, Elisabeth I.
Vaishampayan, Ulka N.
Flaig, Thomas W.
Emamekhoo, Hamid
Pinski, Jacek K.
Kalebasty, Arash Rezazadeh
Maly, Joseph J.
Moon, Helen
Smith, Matthew R
Scher, Howard I
Lara, Primo N, Jr
Yu, Evan Y
George, Daniel J
Chi, Kim N
Danila, Daniel C
Mason, Gary E
Espina, Byron M
Zhao, Xin
Urtishak, Karen A
Francis, Peter
Lopez-Gitlitz, Angela
Pokaż więcej
Źródło:
In The Lancet Oncology March 2022 23(3):362-373
Czasopismo naukowe
Tytuł:
Second-line cabozantinib after sorafenib treatment for advanced hepatocellular carcinoma: a subgroup analysis of the phase 3 CELESTIAL trial
Autorzy:
Kelley, RobinKate
Ryoo, Baek-Yeol
Merle, Philippe.
Park, Joong-Won
Bolondi, Luigi
Chan, Stephen L.
Lim, HoYeong
Baron, Ari D.
Parnis, Francis
Knox, Jennifer
Cattan, Stéphane
Yau, Thomas
Lougheed, Julie C.
Milwee, Steven
El-Khoueiry, Anthony B.
Cheng, Ann-Lii
Meyer, Tim
Abou-Alfa, Ghassan K.
Pokaż więcej
Źródło:
In ESMO Open 2020 5(4)
Czasopismo naukowe
Tytuł:
A phase II trial of nivolumab followed by ipilimumab and nivolumab in advanced non‐clear‐cell renal cell carcinoma.
Autorzy:
Conduit, Ciara
Davis, Ian D.
Goh, Jeffrey C.
Kichenadasse, Ganessan
Gurney, Howard
Harris, Carole A.
Pook, David
Krieger, Laurence
Parnis, Francis
Underhill, Craig
Adams, Diana
Roncolato, Felicia
Joshua, Anthony
Ferguson, Tom
Prithviraj, Prashanth
Morris, Michelle
Harrison, Michelle
Begbie, Stephen
Hovey, Elizabeth
George, Mathew
Pokaż więcej
Źródło:
BJU International; Feb2024 Supplement 1, Vol. 133, p57-67, 11p
Czasopismo naukowe
Tytuł:
Corrigendum to “Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma” [Eur Urol 2023]
Autorzy:
Ernst, Matthew S.
Navani, Vishal
Wells, J. Connor
Donskov, Frede
Basappa, Naveen
Labaki, Chris
Pal, Sumanta K.
Meza, Luis
Wood, Lori A.
Ernst, D. Scott
Szabados, Bernadett
McKay, Rana R.
Parnis, Francis
Suarez, Cristina
Yuasa, Takeshi
Lalani, Aly-Khan
Alva, Ajjai
Bjarnason, Georg A.
Choueiri, Toni K.
Heng, Daniel Y.C.
Pokaż więcej
Źródło:
In European Urology June 2023 83(6):e166-e167
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies